biotherapeutic apoptosis inhibitor (Apogenix)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namebiotherapeutic apoptosis inhibitor (Apogenix)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis inhibitors
TargetsUpdating
Therapy Area/IndicationsSpinal Cord InjuriesStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesApogenix Biotechnology AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApogenix Biotechnology AG
Active IndicationsN/A
Inactive IndicationsSpinal Cord InjuriesStroke

Other Information

ATC CodeN/A
Related LinksN/A